Pravastatin and Niacin: Can You Take Them Together?

High: Consult Your DoctorConflict
Learn about each ingredient:PravastatinNiacin

Quick answer

Niacin adds to pravastatin's risk of muscle injury (myopathy), including rare rhabdomyolysis, a severe breakdown of muscle that can harm the kidneys. The pravastatin label lists niacin among the drugs that may increase this risk, reports cases with the combination and asks prescribers to weigh the benefit and watch for muscle symptoms. Its drug study found niacin did not raise pravastatin levels, so the risk comes from the two muscle effects adding up. Unlike the rosuvastatin and simvastatin labels, which name lipid-modifying doses of 1 gram a day or more, the pravastatin label sets no dose, and the size of the risk has been measured only with simvastatin, where adding niacin raised definite myopathy about 4-fold.

Do not add niacin for cholesterol to pravastatin unless your prescriber has decided the benefit outweighs the muscle risk and is following you. Because the label sets no dose, check any high-strength B3 product with your doctor or pharmacist, and report new muscle pain, weakness or dark urine promptly.

What happens?

Pravastatin can injure muscle, and its label says niacin may add to that risk of myopathy and rare rhabdomyolysis.

1

Added muscle risk

Pravastatin can cause myopathy on its own, and its label says niacin may add to that risk.

2

Not higher drug levels

In the label's drug study, niacin did not raise pravastatin blood levels; the two muscle effects add up instead.

3

Rare kidney danger

In rare cases muscle injury becomes rhabdomyolysis, which releases muscle proteins that can harm the kidneys.

Niacin did not raise pravastatin levels (exposure <strong>down 3.6 percent</strong>), and the label sets <strong>no niacin dose</strong> for its warning.

Why is this important?

This is an FDA label warning, and the size of the muscle risk was measured in one of the largest niacin trials ever run, with another statin.

Label-reported cases

The pravastatin label reports cases of myopathy and rhabdomyolysis with niacin and asks prescribers to weigh the benefit.

Measured with another statin

With simvastatin, adding extended-release niacin raised definite myopathy about 4-fold (0.16 versus 0.04 percent a year).

No heart benefit to offset it

In two large trials of people on a statin, adding niacin did not reduce heart attacks, strokes or other major vascular events.

Large trials did not show a heart benefit from adding niacin to a statin, which is why the label asks prescribers to weigh the benefit against the muscle risk.

What should you do?

The practical fix is simple: separate the doses.

Treat niacin for cholesterol as a prescriber decision

Best practical schedule

Before starting niacin
Ask your prescriber before adding any niacin product sold for cholesterol, and show your pharmacist any high-strength niacin label.
Every day on both
If your prescriber chose the combination, take both as prescribed and notice any new muscle symptoms, especially early on and after dose increases.
If symptoms appear
Call your doctor about unexplained muscle pain, tenderness, weakness or dark urine; your doctor may check your CK level.

Important reminders

  • •The pravastatin label does not set a niacin dose; other statin labels use 1 gram a day or more, far above multivitamin amounts.
  • •Niacinamide is a different form of vitamin B3 and is not what the warning names.
  • •Slow-release niacin still raised muscle problems in the large simvastatin trial.
  • •Never stop or change pravastatin on your own; talk to your doctor first.

Because adding niacin to a statin did not reduce heart attacks or strokes in large trials, your prescriber may suggest a different approach if your cholesterol needs more lowering.

Which specific products are affected?

Many common Niacin products can affect this interaction.

Pravastatin products this applies to

Generic pravastatin sodium tablets

Niacin products used for cholesterol

Niaspan and generic extended-release niacinImmediate-release niacin (nicotinic acid)High-strength over-the-counter niacin sold for cholesterolSlow-release or sustained-release niacin supplements

Other sources

  • •Standard multivitamins and B-complex products contain far less niacin than the 1 gram a day other statin labels name; the pravastatin label sets no dose.
  • •Niacinamide (nicotinamide) is a different form of vitamin B3 and is not used to lower cholesterol.

Read the Supplement Facts label for the form of vitamin B3 and the amount per serving, and ask your pharmacist if a product is sold for cholesterol.

The bottom line

The pravastatin label says niacin may increase the risk of muscle injury, including rare rhabdomyolysis, and reports cases with the combination; it asks prescribers to weigh the benefit and watch for muscle symptoms. Niacin does not raise pravastatin levels, so the muscle effects add up. The label sets no niacin dose, and the size of the risk is known only from a large trial with simvastatin, where adding niacin raised definite myopathy about 4-fold without lowering major vascular events.

Niacinamide is not what this warning names. If you are unsure about a niacin product, ask your pharmacist.

What happens when you take pravastatin with niacin?

Pravastatin is a statin that lowers LDL cholesterol. Niacin is vitamin B3. In large amounts it is also used to change blood fats, either as a prescription (such as Niaspan) or as a high-strength supplement. Pravastatin can injure muscle, and the pravastatin label says niacin may add to that risk.

  1. Pravastatin can cause myopathy: muscle pain, tenderness or weakness with a rise in the muscle enzyme creatine kinase (CK).
  2. The pravastatin label lists niacin, along with fibrates and colchicine, among the drugs that may increase the risk of myopathy and rhabdomyolysis.
  3. In rare cases, muscle injury becomes rhabdomyolysis, where damaged muscle releases proteins that can harm the kidneys.
  4. The label reports that cases of myopathy and rhabdomyolysis have been observed with the combination. It does not say how often.
  5. This is not about higher pravastatin levels: in the label's drug study, a single 1 gram dose of niacin did not raise pravastatin blood levels (total exposure fell by 3.6 percent). The concern is two muscle effects adding up.

Unlike the rosuvastatin and simvastatin labels, which apply the warning to lipid-modifying doses of 1 gram a day or more, the pravastatin label does not set a niacin dose.

Why is this important?

This is a label warning. The pravastatin label asks prescribers to consider whether the benefit of adding niacin outweighs the higher risk of muscle injury, and to watch for muscle symptoms if they go ahead.

The size of the risk has not been measured with pravastatin. It was measured with simvastatin, another statin: in the HPS2-THRIVE trial, adding extended-release niacin raised definite myopathy about 4-fold, and muscle problems were far more common in participants in China than in Europe.

The extra risk also comes without a proven heart benefit. In two large trials of people already on a statin (simvastatin), adding niacin did not reduce heart attacks, strokes or other major vascular events. That is why niacin is now rarely added to a statin, and why the decision belongs to your prescriber.

What should you do?

The principle: any niacin product taken for cholesterol is a medicine decision, not a supplement add-on, when you take pravastatin.

Before starting niacin: If you take pravastatin and are thinking about a niacin product for cholesterol, talk to your prescriber first. Because the label sets no dose, show your pharmacist any high-strength niacin product before you start it.

Every day while on both: If your prescriber has decided the combination is right for you, take both exactly as prescribed and pay attention to your muscles, especially in the first weeks and after a dose increase of either one.

If symptoms appear: Contact your doctor promptly about unexplained muscle pain, tenderness or weakness, especially with fever, tiredness or dark urine. Do not stop or change pravastatin on your own; your doctor may check your CK level and decide what to change.

Which specific products are affected?

On the medication side, this applies to pravastatin sodium tablets, which are sold in the US as generics.

On the niacin side, the warning names niacin (nicotinic acid). Products used for cholesterol include prescription extended-release niacin (Niaspan and generics), immediate-release niacin, and high-strength over-the-counter niacin. The pravastatin label does not say whether small amounts matter; other statin labels apply the same warning only to 1 gram a day or more, far above what a standard multivitamin or B-complex contains. Niacinamide (nicotinamide), a different form of vitamin B3 found in many multivitamins and skin products, is not used to lower cholesterol and is not the form the warning names. Read the Supplement Facts label for the form and the amount per serving.

The science behind it

The pravastatin sodium tablets prescribing information on DailyMed (sections 5.1 and 7.1) states that niacin, fibrates and colchicine may increase the risk of myopathy and rhabdomyolysis, that cases have been observed with niacin and pravastatin, and that prescribers should weigh the benefit and monitor for muscle symptoms, particularly when starting and when raising the dose of either drug. Its pharmacokinetic table (section 12.3) shows a single 1 gram dose of niacin lowered pravastatin exposure by 3.6 percent, so niacin does not work by raising pravastatin levels.

The best measured rate comes from a different statin. In HPS2-THRIVE, 25,673 adults with vascular disease on simvastatin were randomized to extended-release niacin with laropiprant or placebo. Definite myopathy occurred in 75 people on niacin versus 17 on placebo (risk ratio 4.4) (HPS2-THRIVE Collaborative Group, Eur Heart J 2013, PMID 23444397). Major vascular events did not fall (13.2 versus 13.7 percent) (N Engl J Med 2014, PMID 25014686), and in AIM-HIGH, adding niacin to simvastatin gave no extra benefit over 3 years (N Engl J Med 2011, PMID 22085343).

What was not shown: the large outcome trials of niacin used simvastatin, so the size of the muscle risk with pravastatin is not known, and the pravastatin label gives no dose below which niacin is safe to add.

Frequently Asked Questions

Is the niacin in my multivitamin a problem with pravastatin?

The pravastatin label does not set a dose. Other statin labels apply the same warning to 1 gram a day or more, and multivitamins contain far less. If you are unsure about a product, show the label to your pharmacist.

Does niacin raise pravastatin levels?

No. In the label's drug study, niacin did not raise pravastatin blood levels. The concern is that both can affect muscle.

Why would anyone take niacin with a statin?

Niacin raises HDL cholesterol and lowers triglycerides, so it was once added to statins. In large trials, adding it to a statin did not reduce heart attacks or strokes and raised side effects, so it is now used far less.

Does flush-free or slow-release niacin avoid the problem?

Slow-release niacin does not: the large trial that measured the muscle risk used an extended-release form. Products sold as flush-free were not tested. Ask your pharmacist what form of niacin a product contains and how much.

What muscle symptoms should I watch for?

Unexplained muscle pain, tenderness or weakness, especially with fever, feeling unwell or dark urine. Contact your doctor promptly rather than waiting.

Is niacinamide the same as niacin?

No. Niacinamide is another form of vitamin B3 that is not used to lower cholesterol and is not the form the label warning names.

Key takeaways

  • The pravastatin label says niacin may increase the risk of muscle injury, and cases of myopathy and rhabdomyolysis have been observed with the combination.
  • Unlike some other statin labels, the pravastatin label does not set a niacin dose.
  • Niacin does not raise pravastatin levels; the two muscle effects add up.
  • With simvastatin, adding extended-release niacin raised definite myopathy about 4-fold without reducing major vascular events.
  • Report new muscle pain, weakness or dark urine promptly, and never change pravastatin on your own.

References

Primary evidence for this article. Always consult your healthcare provider for personal medical advice.

Related Interactions

Other interactions you should know about

Lovastatin + Niacin

high

Niacin taken at cholesterol-lowering amounts (1 gram a day or more) adds to lovastatin's risk of muscle injury (myopathy), including rare rhabdomyolysis, a severe breakdown of muscle that can harm the kidneys. The lovastatin label says to use caution with this combination because niacin can cause myopathy on its own, asks prescribers to weigh the benefit against the risk, and notes that in uncontrolled studies most patients who developed myopathy on lovastatin were also taking cyclosporine, gemfibrozil or niacin. The rate was measured with simvastatin, another statin: in a trial of 25,673 adults, adding extended-release niacin raised definite myopathy about 4-fold and did not reduce major vascular events. The small amounts of niacin in a multivitamin are not what the label describes.

Atorvastatin + Niacin

high

Adding cholesterol-dose niacin to atorvastatin raises the risk of muscle injury (myopathy, rarely rhabdomyolysis) without improving cardiovascular outcomes in patients already well treated with a statin.

Gemfibrozil + Red Yeast Rice

high

Red yeast rice supplies monacolin K, a compound chemically identical to the statin lovastatin. Combining it with gemfibrozil, a fibrate, can add up to serious muscle injury. The fibrate is itself toxic to muscle and also raises circulating statin levels by interfering with how the statin is cleared, so the two effects stack toward myopathy and, in the worst case, rhabdomyolysis with kidney injury.

Pravastatin + Red Yeast Rice

moderate

Red yeast rice contains monacolin K, a compound chemically identical to the statin lovastatin. Taking it alongside pravastatin means two HMG-CoA reductase inhibitors are active at the same time, so their cholesterol-lowering statin effect and their potential for muscle injury (muscle pain, and rarely rhabdomyolysis) add together. Because pravastatin is water-soluble and is not broken down by the CYP3A4 enzyme, this is not a metabolic (drug-processing) interaction; it is simply the additive effect of stacking two statin-type ingredients, made harder to gauge by red yeast rice's variable, unlabeled monacolin content.

Niacin + Red Yeast Rice

moderate

Red yeast rice contains monacolin K, which is chemically identical to the statin lovastatin, so it behaves as a low-dose statin. Lipid-modifying amounts of niacin can independently injure skeletal muscle, and combining a lovastatin-class agent with such niacin can add to the risk of muscle pain or damage (including, rarely, rhabdomyolysis). Because red yeast rice acts as a variable-strength statin, the same additive muscle-toxicity concern applies when it is taken alongside high-dose niacin.

Seville Orange + Atorvastatin

moderate

Seville (bitter) orange juice contains furanocoumarins such as bergamottin and 6',7'-dihydroxybergamottin that inactivate intestinal CYP3A4. In 10 volunteers, a glass raised levels of felodipine, another CYP3A4 drug, by 76 percent compared with ordinary orange juice (dilute grapefruit juice: 93 percent). It has not been tested with atorvastatin. Grapefruit juice in usual amounts raised atorvastatin levels only 19 to 26 percent without changing cholesterol, liver or muscle tests, so Seville orange is rated the same as grapefruit for atorvastatin.

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before making changes to your supplement or medication routine. Pilora does not diagnose, treat, cure, or prevent any disease.

Check all your supplement interactions instantly

Try Pilora Free